ArticleJournal of global health2025
Global burden, quality of care, and cross-country inequalities in Alzheimer's disease and other dementias from 1990 to 2021.
Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Burden of Alzheimer's Disease and Other Dementias Attribute to Metabolic Risks in Western Europe From 1990 to 2023.Diabetes, obesity & metabolism · 2026Article
- The growing burden of dementia in Asia: Comparative insights from Japan, China, and India.The journal of prevention of Alzheimer's disease · 2026Article
- The divergent effects of population aging: comparative analysis of the burden of Alzheimer's disease and other dementias in China and G20 countries, 1990-2050.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As global populations age, the burden of dementia increases, raising challenges for healthcare systems. Care quality is key to supporting individuals with dementia, but few studies have assessed this at a global level. We aimed to assess the burden and care quality of Alzheimer's disease and related dementias (ADRDs) and cross-country inequalities between 1990 and 2021. Methods: We conducted a secondary analysis of the Global Burden of Diseases Study (GBD) 2021, focussing on disability-adjusted life-years (DALYs) and care quality (measured by a variational autoencoder-based Quality of Care Index (QCI-v), range = 1-100) of ADRDs. We assessed trends using average annual percentage changes (AAPCs) and measured cross-country inequalities using the slope index of inequality and concentration index. Results: The global age-standardised DALY rates of ADRDs per 100 000 population slightly increased from 1331.59 (95% confidence interval (CI) = 881.57, 1781.61) in 1990 to 1347.24 (95% CI = 906.36, 1788.12) in 2021, with an AAPC of 0.04% (95% CI = 0.02, 0.05). The global age-standardised QCI-v of ADRDs increased from 51.56 (95% CI = 45.87, 57.26) to 54.27 (95% CI = 48.68, 59.86), with an AAPC of 0.16% (95% CI = 0.12, 0.21). Regions with a low-middle or low sociodemographic index (SDI), as well as the African Region and the South-East Asia Region, experienced an increasing burden, but a decreasing care quality. In 2021, high-middle SDI regions and the Western Pacific Region had the highest burden, while care quality was notably low in low SDI region. The European Region showed the greatest inequality in terms of burden, while the Eastern Mediterranean showed marked disparities in care quality. Conclusions: The disease burden and care quality of ADRDs both increased from 1990 to 2021, accompanied by significant disparities between countries. Regions with low-middle or low SDI, particularly the African and South-East Asia Regions, faced rising burdens and declining care quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.